Skip to main content
. 2021 Jun 30;3(2):dlab091. doi: 10.1093/jacamr/dlab091

Figure 1.

Figure 1.

(a) Asymptomatic M. genitalium infection rate; ****P < 0.0001. (b) The rate of mutations associated with macrolide and/or fluoroquinolone resistance (MRM or QRM, respectively), defined as parC (excluding D82N) or gyrA mutations. MG, Mycoplasma genitalium.